
Ketan K. Badani, MD, discusses whether cytoreductive nephrectomies are efficacious when combined with immunotherapeutic agents in patients with renal cell carcinoma.

Your AI-Trained Oncology Knowledge Connection!

Ketan Badani, MD, is a professor of urology at Icahn School of Medicine at Mount Sinai, New York, NY.

Published: November 5th 2020 | Updated: